Ginkgo Bioworks

Ena Cratsenburg, Chief Business Officer

Oct. 12 | 3:15pm | AVROBIO Ballroom

Boston, MA

(NYSE: DNA)

In-person Presentation

Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. Our mammalian cell engineering foundry is ideally suited to address many outstanding problems in cell therapy, including combinatorial CAR design, synthetic promoter screening, genomic safe harbor discovery, and manufacturing.

www.ginkgobioworks.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions